MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-08-0055186
Orbion Pharmaceuticals Private Limited
Orbion Pharmaceuticals Private Limited - pharma in Kanchipuram, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹178.75 Cr
▲ 36% YoY
Net profit · FY 2025
₹6.51 Cr
Net margin 3.6%
EBITDA · FY 2025
₹22.33 Cr
EBITDA margin 12.5%
Authorised capital
₹175 Cr
Registered with MCA
Paid-up capital
₹175 Cr
Issued & subscribed
Open charges
₹75 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Employees · EPFO
250
Provident fund records
About Orbion Pharmaceuticals Private Limited
Data last updated:
Orbion Pharmaceuticals Private Limited is a foreign private limited company based in Kanchipuram, Tamil Nadu, India, a subsidiary of Bionpharma Inc. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2021FTC143806. Its GSTIN is 33AADCO4767G1ZE (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹175 Cr and a paid-up capital of ₹175 Cr. It is led by directors including Ashok Kumar Hegde (Managing Director) and Mridul Dhanuka.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sipcot Industrial Park, Kanchipuram, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹178.75 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹6.51 Cr (net margin 3.6%) and EBITDA of ₹22.33 Cr (EBITDA margin 12.5%). Revenue has grown at a compounded annual rate (CAGR) of 108% over three years.
The company has about 250 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹75 Cr on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹174.99 Cr; the latest was in September 2021.
Orbion Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-08-0055186).
Company details
CIN U24100TN2021FTC143806
Registration Number 143806
Incorporation Date 31 May 2021
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Bionpharma Inc
MSME Classification Medium
Udyam Registration UDYAM-TN-08-0055186
Recognitions & Rankings of Orbion Pharmaceuticals
Contact details
Orbion Pharmaceuticals Private Limited's registered office is in Kanchipuram, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot B5 (Part) & Plot B6 (Part) Sipcot Industrial Park Irrungatukottai Sriperumbudur Tal, Uk, Kanchipuram, Tamil Nadu, India – 602117
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Orbion Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Orbion Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Orbion Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Orbion Pharmaceuticals Private Limited, buy the company report.
Financials of Orbion Pharmaceuticals Private Limited
FY 2025 filings availableOrbion Pharmaceuticals Private Limited reported revenue of ₹178.75 Cr (up 36% YoY) for FY 2025.
Revenue · FY 2025
₹178.75 Cr ▲ 36%
Net profit · FY 2025
₹6.51 Cr margin 3.6%
EBITDA · FY 2025
₹22.33 Cr margin 12.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 108%
EBITDA CAGR growth
1 year
▲ 147%
3 years · compounded
▲ 63%
Revenue has grown at a compounded annual rate (CAGR) of 108% over three years, including 36% growth in the latest year. EBITDA rose 147% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹22.33 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹6.51 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 12.5% | |||
| Net Profit Margin | 3.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Orbion Pharmaceuticals Private Limited, buy the company report.
Board of directors of Orbion Pharmaceuticals Private Limited
Orbion Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mridul Dhanuka Also directs: Orchid Pharma Limited, Dhanuka Laboratories Limited, Orchid Bio-Pharma Limited and 1 more | Director | 31 May 2021 | 5 Years 5 Months | Current |
| Bajrang Dass Garg | Director | 17 Aug 2021 | 5 Years 2 Months | Current |
| Phanindranath Ramachandran Punji Also directs: Nuwill Research and Innovations Private Limited | Director | 17 Aug 2021 | 5 Years 2 Months | Current |
| Ashok Kumar Hegde Also directs: Nuwill Research and Innovations Private Limited | Managing Director | 31 May 2021 | 5 Years 5 Months | Current |
Auditor
Orbion Pharmaceuticals Private Limited is audited by SUNDARAM & SRINIVASAN for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNDARAM & SRINIVASAN | FY 2022 | 004207S |
Shareholding
The shareholding of Orbion Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Orbion Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹75 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jul 2023 | 100750600 | Hdfc Bank Limited | ₹75 Cr | Open |
To see the full charge records of Orbion Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Orbion Pharmaceuticals Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹174.99 Cr; the latest was in September 2021.
Total deals
1
Funding round
1
Disclosed funding
₹174.99 Cr
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2021 | Funding round | ₹174.99 Cr | Investors: Bionpharma Health Inc, Orchid Pharma Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Orbion Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orbion Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Orbion Pharmaceuticals Private Limited has a workforce of 250 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
250
Active EPFO establishments
1
Employee growth
20.77%
GST
Orbion Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCO4767G1ZE | Tamil Nadu | Active | 08 Jul 2021 |
| 33AADCO4767G2ZD | Tamil Nadu | Active | 09 Mar 2023 |
To see the full GST registrations and return filing status of Orbion Pharmaceuticals Private Limited, buy the company report.
Recent activity
Orbion Pharmaceuticals Private Limited has 5 board changes on record since 2021: 4 appointments and 1 cessation. The latest: Ashok Kumar Hegde ceased to be Director on 27 Aug 2021.
AGM
Orbion Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 75.00 Cr registered on 17 Jul 2023 with Charge ID 100750600 was modified on 25 Sep 2025.
Filing
Orbion Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 75.00 Cr with Charge ID 100750600 was registered on 17 Jul 2023.
Ceased
Ashok Kumar Hegde ceased to be Director.
Appointed
Bajrang Dass Garg was appointed as Director.
Appointed
Phanindranath Ramachandran Punji was appointed as Director.
Appointed
Ashok Kumar Hegde was appointed as Managing Director.
Appointed
Mridul Dhanuka was appointed as Director.
Incorporation
31 May 2021
Orbion Pharmaceuticals Private Limited was registered on 31 May 2021 with Roc Chennai & aged 5 years 5 months as per MCA records.
Frequently asked questions
Orbion Pharmaceuticals is an active foreign private limited company based in Kanchipuram, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 May 2021 (5+ years old) and is registered under CIN U24100TN2021FTC143806.
Orbion Pharmaceuticals has 4 current directors:
- Ashok Kumar Hegde - Managing Director
- Mridul Dhanuka - Director
- Bajrang Dass Garg - Director
- Phanindranath Ramachandran Punji - Director
The latest financial statements of Orbion Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Orbion Pharmaceuticals is 33AADCO4767G1ZE, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 33AADCO4767G2ZD (Tamil Nadu).
The CIN (Corporate Identification Number) of Orbion Pharmaceuticals is U24100TN2021FTC143806. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orbion Pharmaceuticals was incorporated on 31 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
Orbion Pharmaceuticals has 1 deal on record (1 funding round), with disclosed funding of ₹174.99 Cr; the latest was in September 2021.
Ashok Kumar Hegde ceased to be Director on 27 Aug 2021. Bajrang Dass Garg was appointed as Director on 17 Aug 2021. Phanindranath Ramachandran Punji was appointed as Director on 17 Aug 2021. Orbion Pharmaceuticals has 5 board changes on record in total.
Yes, Orbion Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-08-0055186).
The registered office of Orbion Pharmaceuticals is at Plot B5 Part & Plot B6 Part Sipcot Industrial Park Irrungatukottai Sriperumbudur Tal, Uk, Kanchipuram, Tamil Nadu, India – 602117.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages